Viridiana Cano

Senior Global Medical Director
Sanofi Genzyme, Cambridge, MA, USA

Presentation(s):

• OC 40.3 - Consumption of On-demand Factor Concentrates and Bypassing Agents for Management of Breakthrough Bleeds with Fitusiran Prophylaxis in People with Haemophilia A or B: An Analysis of Two Phase 3 Studies

  Monday, July 11, 2022
  3:15 PM – 3:30 PM